Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development.
The search for a cytotoxic T lymphocyte (CTL)-inducing malaria vaccine has moved forward from epitope identification to planning stages of safety and immunogenicity trials of candidate vaccines. Development of CTL-inducing vaccine candidates has taken center stage based on the observation that CTL-mediated protection might be the dominant mechanism by which sterile immunity is achieved in irradiated sporozoite immunization experiments in humans and laboratory animals. However, studies in naturally infected individuals living in endemic areas, as reviewed here by Michael Aidoo and Venkatachalam Udhayakumar, have revealed that CTL induction might be influenced by factors such as parasite variants, host genes, other infections and transmission patterns. The influence of these factors on CTL induction has been demonstrated individually and in various combinations in controlled animal experiments. However, in naturally infected humans, they are presented in a complex host-parasite-environment interaction, in a manner that is not easily achieved in laboratory-based experiments. Understanding these interactions is crucial for the development and testing of CTL-inducing vaccines for humans.
Aidoo
M
M
Molecular Vaccine Section, Immunology Branch, Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. Mha3@cdc.gov
Udhayakumar
V
V
D000595:Amino Acid Sequence; D000818:Animals; D000953:Antigens, Protozoan / Q000737:chemistry; D000939:Epitopes / Q000737:chemistry; D005805:Genes, MHC Class I / Q000276:immunology; D015234:HLA-A Antigens / Q000737:chemistry / Q000276:immunology; D006790:Host-Parasite Interactions; D006801:Humans; D016778:Malaria, Falciparum / Q000276:immunology* / Q000517:prevention & control / Q000635:transmission; D051379:Mice; D008969:Molecular Sequence Data; D010963:Plasmodium falciparum / Q000276:immunology*; D011110:Polymorphism, Genetic / Q000235:genetics / Q000276:immunology; D016052:Protozoan Vaccines / Q000276:immunology* / Q000592:standards; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000953:Antigens, Protozoan; D000939:Epitopes; D015234:HLA-A Antigens; D016052:Protozoan Vaccines